the present invention is directed to bistriazene compounds , pharmaceutical compositions containing effective anti - cancer amounts of these compounds , a method for treating cancer comprising administering to affected subjects an anti - cancer effective amount of a bistriazene compound , and the use of bistriazene compounds as crosslinking reagents applicable to the synthesis and manipulation of polymeric macromolecules .